Romance novels may have negative effects on health

By Admin
In an essay published in the Journal of Family Planning and Reproductive Health Care, relationship psychologist Susan Quilliam suggested that romance n...

In an essay published in the Journal of Family Planning and Reproductive Health Care, relationship psychologist Susan Quilliam suggested that romance novels cause women to make misinformed choices with damaging effects to their health.

Quilliam criticised the novels for portraying idealistic relationships, sex and pregnancies.

Quilliam proposed that "The values of romantic fiction...sometimes run totally counter to those which women's health practitioners] espouse."

“We teach that sex may be wonderful and relationships loving, but neither are ever perfect and that idealising them is the short way to heartbreak,” she said.

READ MORE FROM THE WDM CONTENT NETWORK:

To read the latest edition of Healthcare Global, click here

Romantic fiction is said to be particularly dangerous for its positive portrayal of unprotected sex. Condoms are portrayed as unromantic and therefore rarely used.

Mills & Boon, a major publisher of romance fiction, opposed the essay’s suggestions. They released a statement declaring: “Mills & Boon is synonymous with the romantic fiction genre, which is of course an enjoyable means of escaping everyday life, but not a guide to reality. Our readers are intelligent enough to understand the difference, just as the many fans of rom coms and chick flicks would not choose to mirror in their lives what they see on film."

Share

Featured Articles

Comarch Diagnostic Point Boost for European Health Insurance

Healthtech specialist Comarch introduces Diagnostic Point, designed to improve health insurance across European markets

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Procurement & Supply Chain

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma